英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

retrial    音标拼音: [ritr'ɑɪəl]
n. 再审,复试,再试验

再审,复试,再试验

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Drug Approvals and Databases | FDA
    Downloadable data files FDA Adverse Event Reporting System (FAERS) Public Dashboard Inactive Ingredient Search for Approved Drug Products Search More information Medication Guides Search More
  • FDA approves Denalis Hunter syndrome drug
    The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease after a string of high-profile rejections for rare disease candidates In approving
  • FDA-Approved Treatments for Alzheimers
    FDA-Approved Drugs For Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia
  • FDA Approves Treatment for Serious Liver Disease Known as . . .
    The U S Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (excessive scar
  • New FDA Drug Approvals for 2026 - Drugs. com
    Up to date information on the latest FDA drug approvals Includes list of most recent approvals, the conditions approved for, and the approval history
  • Denali Therapeutics Announces U. S. FDA Approval of AVLAYAH . . .
    First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease First FDA-approved medicine in emerging new class of biotherapeutics that leverage transferrin receptor to cross blood-brain barrier Denali’s first medicine enabled by its TransportVehicle™ platform designed to deliver biotherapeutics to whole body, including brain Rare
  • UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA . . .
    "The FDA approval of UPLIZNA marks a significant turning point for IgG4-RD patients and physicians who now have a proven treatment that targets a key driver of the disease, reducing the risk of flares and reliance on harmful long-term steroid use," said Jay Bradner, M D , executive vice president of Research and Development at Amgen
  • Drugs@FDA - Food and Drug Administration
    Drugs@FDA includes most of the drug products approved since 1939 The majority of patient information, labels, approval letters, reviews, and other information are available for drug products approved since 1998
  • Search Orphan Drug Designations and Approvals
    This page searches the Orphan Drug Product designation database Searches may be run by entering the product name, orphan designation, and dates Results can be displayed as a condensed list, detailed list, or an Excel spreadsheet Click for detailed instructions
  • FDA Approves Semaglutide to Reduce Risk of Kidney Disease . . .
    Semaglutide, marketed as Ozempic, recently became the first glucagon-like peptide 1 (GLP-1) receptor agonist approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes





中文字典-英文字典  2005-2009